Regions Midatlantic | Philadephia
Sept 18, 2007
Wells Real Estate Investment Trust II has acquired a three-story, Class-A office property in Chesterbrook Corporate Center in suburban Philadelphia, leased to Shire Pharmaceuticals until 2017, Wells REIT II acquired the building from Grosvenor Investment Management US Inc., on behalf of a pension fund client. Financial terms were not disclosed. Shire, headquartered in the United Kingdom, is a global specialty biopharmaceuticals company. The 114,000-square-foot building, 100 percent occupied by Shire, is currently undergoing a major renovation. The deal is Wells REIT II’s third acquisition in Pennsylvania, and the first in Metro Philadelphia.
Wells Real Estate Investment Trust II has acquired a three-story, Class-A office property in Chesterbrook Corporate Center in suburban Philadelphia, leased to Shire Pharmaceuticals until 2017, Wells REIT II acquired the building from Grosvenor Investment Management US Inc., on behalf of a pension fund client. Financial terms were not disclosed. Shire, headquartered in the United Kingdom, is a global specialty biopharmaceuticals company. The 114,000-square-foot building, 100 percent occupied by Shire, is currently undergoing a major renovation. The deal is Wells REIT II’s third acquisition in Pennsylvania, and the first in Metro Philadelphia.
Recent Philadelphia Headlines
July 03, 2008
July 03, 2008
June 30, 2008
June 25, 2008
June 24, 2008



